Acute retinal necrosis
| Acute retinal necrosis | |
|---|---|
| Synonyms | ARN |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Eye pain, vision loss, red eye, photophobia |
| Complications | Retinal detachment, blindness |
| Onset | Rapid |
| Duration | Variable |
| Types | N/A |
| Causes | Herpes simplex virus, Varicella zoster virus |
| Risks | Immunocompromised state, HIV/AIDS, organ transplant |
| Diagnosis | Clinical examination, Ophthalmic imaging, PCR testing |
| Differential diagnosis | Cytomegalovirus retinitis, Toxoplasmosis, Syphilitic uveitis |
| Prevention | N/A |
| Treatment | Antiviral therapy, corticosteroids, vitrectomy |
| Medication | N/A |
| Prognosis | Variable, often poor without treatment |
| Frequency | Rare |
| Deaths | N/A |
Acute Retinal Necrosis (ARN) is a rare but serious eye condition characterized by the rapid inflammation and necrosis of the retina. It is typically caused by a viral infection, most commonly by members of the herpesvirus family, including Herpes simplex virus (HSV) types 1 and 2, Varicella zoster virus (VZV), and less frequently by Epstein-Barr virus (EBV) and Cytomegalovirus (CMV).
Symptoms[edit]
The initial symptoms of ARN can be non-specific and may include eye pain, redness of the eye, sensitivity to light, and blurred vision. As the condition progresses, patients may experience a rapid decline in vision due to the involvement of the retina and the underlying choroid layer.
Causes[edit]
ARN is primarily caused by a reactivation of latent herpesvirus infection within the body. The exact mechanism by which the virus reactivates and targets the retina is not fully understood, but it is believed to involve the immune system's inability to keep the virus in check, leading to widespread inflammation and tissue damage.
Diagnosis[edit]
Diagnosis of ARN involves a comprehensive eye examination, including fundoscopy, which reveals characteristic patterns of retinal necrosis. Additional tests may include blood tests to identify the causative virus, polymerase chain reaction (PCR) testing of the vitreous or aqueous humor to detect viral DNA, and imaging studies such as fluorescein angiography to assess the extent of retinal involvement.
Treatment[edit]
Treatment of ARN is aimed at controlling the viral infection and reducing inflammation to prevent further damage to the retina. This typically involves the use of antiviral medications such as Acyclovir, Valacyclovir, or Famciclovir, often in combination with corticosteroids to reduce inflammation. In some cases, surgical intervention, such as vitrectomy, may be necessary to remove the vitreous gel and replace it with a saline solution to maintain the eye's shape and prevent retinal detachment.
Prognosis[edit]
The prognosis for patients with ARN can vary widely depending on the promptness of diagnosis and treatment. Early intervention with antiviral therapy and corticosteroids can help to preserve vision, but some patients may still experience significant vision loss or blindness in the affected eye. Regular follow-up with an ophthalmologist is essential for monitoring the condition and managing any complications.
Prevention[edit]
Prevention of ARN involves the management of systemic herpesvirus infections and maintaining a healthy immune system. For individuals with a history of herpesvirus infections, antiviral prophylaxis may be recommended to prevent reactivation.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian